June 9, 2023

FDA approves first gene therapy for hemophilia B

On November 22, 2022, the FDA approved Hemgenix®, an adeno-associated virus vector-based gene therapy indicated for the treatment of adults with Hemophilia B (congenital Factor IX deficiency) who:

  • Currently use Factor IX (FIX) prophylaxis therapy, or
  • Have current or historical life-threatening hemorrhage, or
  • Have repeated, serious spontaneous bleed episodes

The HOC has individuals who expressed interest in Hemgenix, have completed their pre-screening eligibility and are in the final stages of meeting all the requirements needed for gene therapy The HOC medical team has participated in extensive educational trainings and are knowledgeable about all aspects of gene therapy with Hemgenix®. This includes, but is not limited to, preparation for treatment, administration of the therapy, and close monitoring once it has been given.

If you have any questions or want more information about Hemgenix®, please contact your hemophilia treatment center.

LEARN MORE ABOUT HEMGENIX®

Recent Posts

Bleeding Disorders Advocacy: A Year-Round Engagement

Advocacy is a powerful way to make a lasting difference for the bleeding disorders community. Whether it’s attending events like Great Lakes Hemophilia Foundation's Wisconsin Advocacy Day or sharing your story directly with legislators, every effort contributes to...

The Impact of Gene Therapy with Dave Novak & Rochelle Ginter

Today on Beyond the Bleeds, we welcome Rochelle Ginter, RN, at the Hemophilia Outreach Center in Green Bay, Wisconsin, and David Novak, who shares his experience receiving gene therapy for hemophilia A. We delve into the mechanics of hemophilia A, the latest...

Aging with Bleeding Disorders: Senior Care Tips and Considerations

Understanding the Challenges of Aging with Bleeding Disorders The Impact of Aging on Bleeding DisordersAs individuals with bleeding disorders age, they may face unique challenges that require tailored care. Factors such as joint health deterioration, increased risk of...

Exploring Health Literacy and Resilience with Dr. Bridget Freeman

Today on Beyond the Bleeds, we welcome Dr. Bridget Freeman to discuss the essential elements of comprehensive health outcomes. We dive into the multifaceted approaches required to ensure long-lasting health improvements, encompassing agriculture, child education,...

Social Media